Xygrel-AS Combikit
Images are for reference. Actual packaging may vary.
Box of 1 kit • OtherPrescription requiredSchedule H
Xygrel-AS Combikit
Ticagrelor (90mg) + Aspirin (75mg)
₹367.03
Box of 1 kit • Other
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Ticagrelor 90 mg
+1 more active ingredient
How It Works
Ticagrelor reversibly inhibits the P2Y12 receptor on platelets, preventing their activation and aggregation.
Aspirin irreversibly inhibits COX-1 and COX-2 enzymes, leading to decreased production of thromboxane A2 and prostaglandins.
Medicine Strength
90 mg
All Active Ingredients
Ticagrelor90 mg
Aspirin75 mg
Uses & Benefits
Medical applications
Anti-inflammatory
Xygrel-AS Combikit contains a combination of Ticagrelor (90 mg) and Aspirin (75 mg), formulated for the prevention of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) or a history of myocardial infarction. Ticagrelor is a reversible oral P2Y12 receptor antagonist that inhibits platelet aggregation by preventing adenosine diphosphate (ADP) from binding to its platelet receptor, thereby reducing the risk of clot formation.
Read full descriptionShow less
Aspirin, a nonsteroidal anti-inflammatory drug (NSAID), irreversibly inhibits cyclooxygenase-1 (COX-1), leading to decreased thromboxane A2 production and subsequent inhibition of platelet aggregation. The combination of these agents provides a dual antiplatelet effect, enhancing efficacy in reducing the incidence of cardiovascular death, myocardial infarction, and stroke compared to monotherapy.
Xygrel-AS Combikit is indicated for use in patients undergoing percutaneous coronary intervention (PCI) or those with unstable angina or non-ST elevation myocardial infarction (NSTEMI). It should be used under strict medical supervision due to potential risks including bleeding complications, dyspnea, and hypersensitivity reactions. Dosage adjustments and contraindications must be carefully considered, particularly in patients with active bleeding, history of intracranial hemorrhage, or severe hepatic impairment.
Regular monitoring and adherence to prescribed regimens are essential to optimize therapeutic outcomes.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
Customer Reviews
0 reviews for Xygrel-AS Combikit
